Hilary McElwaine-Johnn

Publications

301

Citations

H-Index

2009

Active since

Affiliations

South Texas Accelerated Research Therapeutics(Current)

Hilary McElwaine-Johnn is an author at South Texas Accelerated Research Therapeutics specializing in influenza vaccines, cross-protection, and egg-based vaccine production.

Top concepts

MedicineVaccinationPublic HealthCross-protectionVaccine EfficacyInfluenza VaccinesPreventive MedicineEgg-based Vaccine Production

Publications per year

2009–2021

Publications

DNA vaccination protects against an influenza challenge in a double-blind randomised placebo-controlled phase 1b clinical trial

Suzanne Jones, Kirsten Evans, Hilary McElwaine-Johnn et al. · Vaccine · 2009 · 140 citations

Vaccination, Cross-protection, Preventive Medicine +11

A phase 1 dose escalation study of the oncolytic adenovirus enadenotucirev, administered intravenously to patients with epithelial solid tumors (EVOLVE)

Jean‐Pascal Machiels, Ramón Salazar, Sylvie Rottey et al. · Journal for ImmunoTherapy of Cancer · 2019 · 100 citations · Full text

Preclinical Development and First-in-Human Study of KA2507, a Selective and Potent Inhibitor of Histone Deacetylase 6, for Patients with Refractory Solid Tumors

Apostolia M. Tsimberidou, Philip Beer, Carrie Cartwright et al. · Clinical Cancer Research · 2021 · 61 citations · Full text

Rows per page

1–3 of 3